Skip to main content

Peer Review reports

From: Real-world efficiency of lenvatinib plus PD-1 blockades in advanced hepatocellular carcinoma: an exploration for expanded indications

Original Submission
19 Jan 2022 Submitted Original manuscript
1 Feb 2022 Reviewed Reviewer Report
12 Feb 2022 Reviewed Reviewer Report
26 Feb 2022 Author responded Author comments - Tingbo Liang
7 Mar 2022 Reviewed Reviewer Report
10 Mar 2022 Reviewed Reviewer Report
Resubmission - Version 2
26 Feb 2022 Submitted Manuscript version 2
Publishing
10 Mar 2022 Editorially accepted
19 Mar 2022 Article published 10.1186/s12885-022-09405-7

You can find further information about peer review here.

Back to article page